Latest News
Beyond the Spot Price: The Changing Landscape of Commodity ETFs
Historically investors have bought physical commodity ETFs to gain direct exposure to the spot price of real assets. These funds provide a straightforward way to hedge against inflation and market vol
Fifth Third Bancorp: Comerica Is Now A Growth Catalyst
Fifth Third Bancorp (FITB) is upgraded to 'Buy' following the successful Comerica acquisition and robust Q2'26 earnings beat. FITB's net interest income surged 48% year-over-year, driven by Comerica i
JEPQ: There's A New Kid In Town
Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ) is rated Buy, while JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) is rated Hold. GPIQ has outperformed JEPQ in recent months, driven by its use of
Iconic candymaker to lay off hundreds, move US headquarters out of New Jersey
Mars Wrigley filed a WARN notice to cut 307 jobs at its Newark headquarters, ending its presence in the New Jersey city as it shifts to Chicago.
Zuckerberg Is Quietly Turning Meta Into A Compute Provider Ahead Of Q2 Earnings
Meta Platforms, Inc.'s Q2 earnings will focus on CapEx guidance (already revised for 2026); market sentiment hinges on Meta's ability to monetize AI infrastructure investments. Meta's recent pivot tow
Burger King launches new Whopper rule that picky eaters will love
This week in Whoppers.
IHAK: Why The Onus Is On The Cybersecurity Bulls In The Q2 Earnings Season
IHAK, the iShares Cybersecurity and Tech ETF, is downgraded to Hold after outperforming the S&P 500 with a 20% return since September 2025. IHAK's valuation is now moderate, matching the S&P 500's P/E
Distribution Solutions Group Announces Controller Buyout; Julie & Holleman Investigating Whether Minority Shareholders Are Receiving Fair Value
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Distribution Solutions Group, Inc. (Nasdaq: DSGR) has agreed to be acquired by its controlling shareholder in a transaction that will cash out the company's
Novo Nordisk's Rally Has Room To Run Driven By Oral Wegovy's Momentum
Novo Nordisk shares have rallied approximately 27% since my previous coverage, driven by accelerating commercial momentum behind oral Wegovy and expanding investor confidence. Oral Wegovy captured rou
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Planet Fitness, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PLNT
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Planet Fitness, Inc. (NY
Options Bulls Target Microsoft Stock Before Earnings
Microsoft Corp (NASDAQ:MSFT) is scheduled to report fiscal fourth-quarter earnings after the close on Wednesday, July 29.
Hugging Face Latest Company Dealing With AI Cyberattacks
Hugging Face, whose platform hosts AI datasets, has reportedly suffered an AI-powered data breach. As TechCrunch reported Monday (July 20), the company revealed the breach last week but said it was st
Paramount-WBD merger on hold after judge grants temporary restraining order
California District Judge Araceli Martínez-Olguín approved a temporary restraining order, putting a 14-day pause on the Paramount-Warner Bros. Discovery merger.
4D Molecular: 'Buy' Wet-AMD Study Readouts 2027 And DME Expansion Opportunity
4D Molecular Therapeutics, Inc. maintains a Buy rating, driven by advancing 4D-150 gene therapy for Wet-AMD and DME into late-stage pivotal trials. FDMT's 4D-150 demonstrated up to 89% reduction in in
Itochu: Focus On IR Day And Capital Returns
ITOCHU Corporation remains a 'Buy' as I see strong catalysts from portfolio restructuring initiatives and enhanced cash distributions. Management targets 15.1% normalized bottom-line growth for FY2026
GE Vernova Stock Powers Higher Ahead of Earnings
GE Vernova Inc (NYSE:GEV) will report second-quarter earnings before the market opens on Wednesday, July 22.
ADMA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ADMA
New York, New York--(Newsfile Corp. - July 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9,
UroGen Pharma: Reimbursement Is Turning Zusduri Into A Workflow Moat
UroGen Pharma is shifting NMIBC treatment from surgery to office-based chemoablative therapy with ZUSDURI, driving a differentiated investment thesis. ZUSDURI revenue surged 109% sequentially to $29.2
ROBLOX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Roblox Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - RBLX
New York, New York--(Newsfile Corp. - July 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Roblox Corporation (NYSE: RBLX) between October 30,
ROSEN, A LEADING LAW FIRM, Encourages GPGI, Inc. f/k/a CompoSecure, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GPGI, CMPO
New York, New York--(Newsfile Corp. - July 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of GPGI,